These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 20920330)

  • 1. Association between the Cytotoxic T-lymphocyte antigen 4 +49G > A polymorphism and cancer risk: a meta-analysis.
    Zheng J; Yu X; Jiang L; Xiao M; Bai B; Lu J; Zhou Y
    BMC Cancer; 2010 Oct; 10():522. PubMed ID: 20920330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The functional cytotoxic T lymphocyte-associated Protein 4 49G-to-A genetic variant and risk of pancreatic cancer.
    Yang M; Sun T; Zhou Y; Wang L; Liu L; Zhang X; Tang X; Zhou M; Kuang P; Tan W; Li H; Yuan Q; Yu D
    Cancer; 2012 Oct; 118(19):4681-6. PubMed ID: 22359319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significant association between cytotoxic T lymphocyte antigen 4 +49G>A polymorphism and risk of malignant bone tumors.
    Yu F; Miao J
    Tumour Biol; 2013 Dec; 34(6):3371-5. PubMed ID: 23900675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Cytotoxic T-lymphocyte Antigen-4 Polymorphisms with Malignant Bone Tumor Risk: A Meta-analysis.
    Zhang C; Hou WH; Ding XX; Wang X; Zhao H; Han XW; Wang WJ
    Asian Pac J Cancer Prev; 2016; 17(8):3785-91. PubMed ID: 27644617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytotoxic T-lymphocyte antigen-4 +49G/A polymorphism is associated with increased risk of osteosarcoma.
    Wang W; Wang J; Song H; Liu J; Song B; Cao X
    Genet Test Mol Biomarkers; 2011; 15(7-8):503-6. PubMed ID: 21453059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current evidence on the cytotoxic T-lymphocyte antigen 4 + 49G > A polymorphism and digestive system cancer risks: a meta-analysis involving 11,923 subjects.
    Xiaolei L; Baohong Y; Haipeng R; Shuzhen L; Jianfeng G; Xiangpo P; Haiyu L; Yuan Y; Dejie Z; Jinhong Y; Huanxin W; Wenhui W; Guohua Y
    Meta Gene; 2015 Dec; 6():105-8. PubMed ID: 26629416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytotoxic T-lymphocyte antigen-4 +49G/A polymorphism and susceptibility to pancreatic cancer.
    Lang C; Chen L; Li S
    DNA Cell Biol; 2012 May; 31(5):683-7. PubMed ID: 22011251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of cytotoxic T-Lymphocyte antigen-4+49A/G gene polymorphism in cutaneous leishmaniasis.
    Al-Ghabban MJS; Al-Bayati NY; Al-Mayah QS; Al-Matubsi HY
    Microb Pathog; 2021 Sep; 158():105073. PubMed ID: 34182077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meta-analysis of the cytotoxic T-lymphocyte antigen 4 gene +6230G/A polymorphism and cancer risk.
    Zhao HY; Duan HX; Gu Y
    Clin Transl Oncol; 2014 Oct; 16(10):879-85. PubMed ID: 24493286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between CTLA-4 exon-1 +49A>G polymorphism and primary biliary cirrhosis risk: a meta-analysis.
    Huang Q; Shao F; Wang C; Qiu LJ; Hu YG; Yu JH
    Arch Med Res; 2011 Apr; 42(3):235-8. PubMed ID: 21722820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional genetic variations in cytotoxic T-lymphocyte antigen 4 and susceptibility to multiple types of cancer.
    Sun T; Zhou Y; Yang M; Hu Z; Tan W; Han X; Shi Y; Yao J; Guo Y; Yu D; Tian T; Zhou X; Shen H; Lin D
    Cancer Res; 2008 Sep; 68(17):7025-34. PubMed ID: 18757416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations between the cytotoxic T lymphocyte antigen 4 polymorphisms and risk of bone sarcomas.
    Fan C; Zhao X; Xu Z
    Tumour Biol; 2015 Jan; 36(1):227-31. PubMed ID: 25230787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of CTLA-4 gene polymorphisms with sporadic breast cancer in Chinese Han population.
    Wang L; Li D; Fu Z; Li H; Jiang W; Li D
    BMC Cancer; 2007 Sep; 7():173. PubMed ID: 17825114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of association between cytotoxic T-lymphocyte antigen-4 -318C/T polymorphism and cancer risk: a meta-analysis of case-control studies.
    Xia W; Shi R; Zheng WL; Ma WL
    Technol Cancer Res Treat; 2013 Dec; 12(6):565-74. PubMed ID: 23745791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CTLA-4 +49 A/G and -318 C/T polymorphisms and susceptibility to multiple sclerosis: a meta-analysis.
    Gyu Song G; Ho Lee Y
    Immunol Invest; 2013; 42(5):409-22. PubMed ID: 23802171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CTLA-4 polymorphisms and systemic lupus erythematosus (SLE): a meta-analysis.
    Zhai JX; Zou LW; Zhang ZX; Fan WJ; Wang HY; Liu T; Ren Z; Dai RX; Ye D
    Mol Biol Rep; 2013 Sep; 40(9):5213-23. PubMed ID: 23922195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. +49G > A polymorphism in the cytotoxic T-lymphocyte antigen-4 gene increases susceptibility to hepatitis B-related hepatocellular carcinoma in a male Chinese population.
    Gu X; Qi P; Zhou F; Ji Q; Wang H; Dou T; Zhao Y; Gao C
    Hum Immunol; 2010 Jan; 71(1):83-7. PubMed ID: 19778566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytotoxic T-lymphocyte associated antigen 4 polymorphism and Hashimoto's thyroiditis susceptibility: a meta-analysis.
    Qiu H; Tang W; Yin P; Cheng F; Wang L
    Endocrine; 2014 Mar; 45(2):198-205. PubMed ID: 23677500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphisms in the CTLA-4 gene and rheumatoid arthritis susceptibility: a meta-analysis.
    Li X; Zhang C; Zhang J; Zhang Y; Wu Z; Yang L; Xiang Z; Qi Z; Zhang X; Xiao X
    J Clin Immunol; 2012 Jun; 32(3):530-9. PubMed ID: 22354566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between cytotoxic T lymphocyte antigen-4 +49A/G, -1722T/C, and -1661A/G polymorphisms and cancer risk: a meta-analysis.
    Geng R; Song F; Yang X; Sun P; Hu J; Zhu C; Zhu B; Fan W
    Tumour Biol; 2014 Apr; 35(4):3627-39. PubMed ID: 24307627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.